TGF-β signaling in colon cancer cells can promote immunosuppression within the tumor microenvironment, which can inhibit the activation and function of immune cells such as T cells and natural killer cells, thereby evading immune surveillance and promoting tumor immune escape (Rizzo et al., 2011; Li et al., 2022b). This evidence concerns the gene TGFB1 and malignant colon neoplasm.